Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice

Blood

Volumn 101, Issue 12, 2003, Pages 5033-5038

  Lee, Tae Hoon ^b   Kim, Sun Uk ^b   Yu, Seong Lan ^b   Kim, Sue Hee ^b   Park, Do Sim ^b   Moon, Hyung Bae ^b   Dho, So Hee ^b   Kwon, Ki Sun ^b   Kwon, Hyun Jeong ^b   Han, Ying Hao ^b   Jeong, Sangkyun ^b   Kang, Sang Won ^b   Shin, Hee Sup ^b   Lee, Kyung Kwang ^b   Rhee, Sue Goo ^b   Yu, Dae Yeul ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CELL LABELING; CELL PROTECTION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EMBRYO; ERYTHROCYTE LIFESPAN; ERYTHROCYTE SHAPE; ERYTHROPOIESIS; EXPERIMENTAL MODEL; HEINZ BODY; HEMATOCRIT; HEMOLYTIC ANEMIA; HOMEOSTASIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETICULOCYTE COUNT; SPLENOMEGALY;

EID: 10744233389     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-08-2548     Document Type: Article

References (30)

1. Chae HZ, Kim IH, Kim K, Rhee SG. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem. 1993;268:16815-16821.
2. Rhee SG, Kang SW, Chang TS, Jeong W, Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 2001;52:35-41.
3. Nemoto Y, Yamamoto T, Takada S, Matsui Y, Obinata M. Antisense RNA of the latent period gene (MER5) inhibits the differentiation of murine erythroleukemia cells. Gene. 1990;91:261-265.
4. Prosperi MT, Apiou F, Dutrillaux B, Goubin G. Organization and chromosomal assignment of two human PAG gene loci: PAGA encoding a functional gene and PAGB a processed pseudogene. Genomics. 1994;19:236-241.
5. Tsuji K, Copeland NG, Jenkins NA, Obinata M. Mammalian antioxidant protein complements alkylhydroperoxide reductase (ahpC) mutation in Escherichia coli. Biochem J. 1995;307:377-381.
6. Shau H, Butterfield LH, Chiu R, Kim A. Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Immunogenetics. 1994;40:129-134.
7. Watabe S, Hasegawa H, Takimoto K, Yamamoto Y, Takahashi SY. Possible function of SP-22, a substrate of mitochondrial ATP-dependent protease, as a radical scavenger. Biochem Biophys Res Commun. 1995;213:1010-1016.
8. Iwahara S, Satoh H, Song DX, et al. Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry. 1995;34:13398-13406.
9. Wen ST, Van Etten RA. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 1997;11:2456-2467.
10. Rabilloud T, Berthier R, Vincon M, Ferbus D, Goubin G, Lawrence JJ. Early events in erythroid differentiation: accumulation of the acidic peroxidoxin (PRP/TSA/NKEF-B). Biochem J. 1995;312:699-705.
11. Cha MK, Yun CH, Kim IH. Interaction of human thiol-specific antioxidant protein 1 with erythrocyte plasma membrane. Biochemistry. 2000;39:6944-6950.
12. Moore RB, Shriver SK. Protein 7.2b of human erythrocyte membranes binds to calpromotin, Biochem Biophys Res Commun. 1997;232:294-297.
13. Kim JR, Yoon HW, Kwon KS, Lee SR, Rhee SG. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal Biochem. 2000;283:214-221.
14. Demple B. A bridge to control. Science. 1998:279:1655-1656.
15. Baronciani L, Beutler E. Prenatal diagnosis of pyruvate kinase deficiency. Blood. 1994;84:2354-2356.
16. Beutler E. G6PD deficiency. Blood. 1994;84:3613-3636.
17. Beutler E, Miwa S, Palek J. Hemolytic anemias. Rev Invest Clin. 1994;Apr(suppl):162-168.
18. Valentine WN, Paglia DE. Erythroenzymopathies and hemolytic anemia: the many faces of inherited variant enzymes. J Lab Clin Med. 1990;115:12-20.
19. Valentine WN, Paglia DE. Red cell metabolism, normal and abnormal implications for red cell aging. Adv Exp Med Biol. 1991;307:125-137.
20. Beutler E. Red cell enzyme defects. Hematol Pathol. 1990;4:103-114.
21. Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductasel gene. Proc Natl Acad Sci U S A. 1996;93:14960-14965.
22. Beutler E, Moroose R, Kramer L, Gelbart T, Forman L. Gamma-glutamylcysteine synthetase deficiency and hemolytic anemia. Blood. 1990;75:271-273.
23. de Haan JB, Bladier C, Griffiths P, et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem. 1998;273:22528-22536.
24. Ho YS, Magnenat JL, Bronson RT, et al. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem. 1997;272:16644-16651.
25. Esposito LA, Kokoszka JE, Waymire KG, Cottrell B, MacGregor GR, Wallace DC. Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radic Biol Med. 2000;28:754-766.
26. Moore RB, Shriver SK, Jenkins LD, Mankad VN, Shah AK, Plishker GA. Calpromotin, a cytoplasmic protein, is associated with the formation of dense cell in sickle cell anemia. Am J Hematol. 1997;56:100-106.
27. Peters LL, Shivdasani RA, Liu SC, et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell. 1996;86:917-927.
28. Shi ZT, Afzal V, Coller B, et al. Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J Clin Invest. 1999;103:331-340.
29. Shartava A, Monteiro CA, Bencsath FA, et al. A posttranslational modification of beta-actin contributes to the slow dissociation of the spectrin-protein 4.1-actin complex of irreversibly sickled cells. J Cell Biol. 1995;128:805-818.
30. Bencsath FA, Shartava A, Monteiro CA, Goodman SR. Identification of the disulfide-linked peptide in irreversibly sickled cell beta-actin. Biochemistry. 1996;35:4403-4408.